The impact of peripheral artery disease (PAD) on survival in implantable cardioverter defibrillator (ICD) patients is poorly understood. Thus, we assessed the risk of PAD in our adult ICD patients with left ventricular dysfunction (ejection fraction [EF] ≤35%). Survival was estimated with Kaplan...
【别名】peripheralarteryembolism 【ICD号】I74 【概述】 周围动脉栓塞(peripheralarterialembolism)指周围动脉被来自某个部 位的血栓或栓子堵塞,继而造成远端发生急性缺血,表现为急性缺血性疼痛和 坏死,并直接影响生活的自主性。除脑动脉栓塞外,最多见的是下肢动脉(髂、 ...
Definitions for outcome of acute myocardial infarction (AMI), stroke, and peripheral artery disease (PAD)-related outcomes OutcomeDefinition AMI Stroke (ischemic or hemorrhagic) PAD-related outcomes ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International Classification of ...
In a Cochrane review, Wasiak and colleagues (2012) examined the effects of percutaneous transluminal coronary rotational atherectomy (PTCRA) for coronary artery disease in patients with non-complex and complex lesions (e.g., ostial, long or diffuse lesions or those arising from in-stent re-ste...
Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021 Peripheral artery disease (PAD) is a global health concern associated with arterial narrowing or blockage, leading to significant morbidity and mortalit...
Coronary artery disease 1.52 1.32-1.74 <.0001 Diabetes 1.56 1.33-1.83 <.0001 Other peripheral bypass surgery Age (per each year of age) 1.048 1.045-1.051 <.0001 Male sex 1.24 1.17-1.33 <.0001 Hypertension 0.91 0.84-0.98 .011 Coronary artery disease 1.50 1.41-1.61 <.0001 Diabetes 1.63 1.53...
Associations between varicose veins and subsequent risk of deep vein thrombosis, pulmonary embolism and peripheral artery disease by duration of follow-up eTable 3. Incidence rates and hazard ratios for deep vein thrombosis in patients with varicose veins vs. propensity score-matched controls presented...
Peripheral arterial disease (PAD) is caused by atherosclerosis that results in ischemia mostly in the lower extremities. Clinical trials including VEGF-A administration for therapeutic angiogenesis have not been successful. The existence of anti-angiogenic isoform (VEGF165b) in PAD muscle tissues is a...
Whether sodium glucose co-transporter 2 inhibitors (SGLT2i) are associated with a lower risk of cardiovascular as well as adverse lower limb events in patients with type-2 diabetes mellitus (T2DM) and concomitant peripheral artery disease (PAD) is unclear. We aimed to evaluate the risk of card...
Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US preventive services task force recommendation statement JAMA, 320 (2) (2018), pp. 177-183 Google Scholar [16] F. Alahdab, et al. A systematic review for the screening for periphe...